RITONAVIR ANALOGOUS COMPOUND USEFUL AS RETROVIRAL PROTEASE INHIBITOR, PREPARATION OF THE RITONAVIR ANALOGOUS COMPOUND AND PHARMACEUTICAL COMPOSITION FOR THE RITONAVIR ANALOGOUS COMPOUND

The present invention describes a new one ritonavir analogous compound that presents significantly superior activity in inhibition of HIV protease. There are also described the usage of the ritonavir analogous compound of the present invention or salt, ester or prodrug thereof as well as the usage o...

Full description

Saved in:
Bibliographic Details
Main Authors BOCKELMANN, MARIA ALICE, FUZETO, CLAUDIO ROBERTO, OLIVEIRA, KESLEY MORAES GODINHO DE, VERNUCCI, THIAGO BOSCARO, ROSATTO, SIMONE SOARES, BAREL, DANIELA CECILIA, FREITAS, MATHEUS PUGGINA DE
Format Patent
LanguageEnglish
French
German
Published 08.09.2010
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention describes a new one ritonavir analogous compound that presents significantly superior activity in inhibition of HIV protease. There are also described the usage of the ritonavir analogous compound of the present invention or salt, ester or prodrug thereof as well as the usage of the compound and its pharmaceutical compositions in medicine, particularly, in the treatment of HIV infection, by itself or in combination with others anti-HIV drugs.
Bibliography:Application Number: EP20050738457